Susquehanna International Group’s Citius Pharmaceuticals CTXR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $59.8K | Buy |
|
|||||
|
2025
Q2 | $22.6K | Buy |
|
|||||
|
2025
Q1 | – | Hold |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $82.6K | Sell |
|
|||||
|
2024
Q2 | $374K | Buy |
|
|||||
|
2024
Q1 | $10.1K | Sell |
|
|||||
|
2023
Q4 | $107K | Buy |
|
|||||
|
2023
Q3 | $33.9K | Sell |
|
|||||
|
2023
Q2 | $180K | Sell |
|
|||||
|
2023
Q1 | $538K | Buy |
|
|||||
|
2022
Q4 | $260K | Buy |
|
|||||
|
2022
Q3 | $66K | Sell |
|
|||||
|
2022
Q2 | $162K | Buy |
|
|||||
|
2022
Q1 | $241K | Sell |
|
|||||
|
2021
Q4 | $283K | Sell |
|
|||||
|
2021
Q3 | $540K | Buy |
|
|||||
|
2021
Q2 | $721K | Buy |
|
|||||
|
2021
Q1 | $175K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $25K | Buy |
|